M&A Deal Summary |
|
|---|---|
| Date | 2021-06-24 |
| Target | Stragen Pharma |
| Sector | Life Science |
| Buyer(s) | ArchiMed |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 38 |
| Sector: Life Science M&A | 5 of 14 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 14 of 21 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2021 M&A | 3 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-12 |
Zyto
Dusseldorf, Germany Zyto is a fully integrated developer, manufacturer and distributor of technologically advanced cancer diagnostics tests and equipment for hospitals, clinics and private medical practices. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-16 |
Aliri
Colorado Springs, Colorado, United States Aliri is a provider of molecular imaging services and products aiming at enhancing the development of new drugs through innovative proprietary technologies. Aliri was founded in 1991 and is based in Colorado Springs, Colorado. |
Buy | - |
